Expertise in
5
conditions

Agnieszka Wierzbowska

Student Scientific Research Club Of Experimental, 
Lodz, LD, PL 
Expertise in
5
conditions
Student Scientific Research Club Of Experimental, 
Lodz, LD, PL 

Overview

Agnieszka Wierzbowska practices practicing medicine in Lodz, Poland.

Ms. Wierzbowska is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Febrile Neutropenia, Agranulocytosis, and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 84 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Student Scientific Research Club Of Experimental, Lodz, LD 90419, Poland
Other Locations
Wroclaw, DS, Poland
Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Open-label, Controlled, Phase 2 Study of Pevonedistat, Venetoclax, and Azacitidine Versus Venetoclax Plus Azacitidine in Adults With Newly Diagnosed Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy
A Randomized, Open-label, Controlled, Phase 2 Study of Pevonedistat, Venetoclax, and Azacitidine Versus Venetoclax Plus Azacitidine in Adults With Newly Diagnosed Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy
Enrollment Status: Completed
Publish Date: October 21, 2025
Intervention Type: Drug
Study Drugs: Pevonedistat, Venetoclax, Azacitidine
Study Phase: Phase 2

84 Total Publications

Beyond Hematology-Current Insights into Chimeric Antigen Receptor (CAR) T-Cell Therapy for Skin and Connective Tissue Disorders.
Beyond Hematology-Current Insights into Chimeric Antigen Receptor (CAR) T-Cell Therapy for Skin and Connective Tissue Disorders.
Journal: Cells
Published: April 09, 2026

Frequently Asked Questions about Agnieszka Wierzbowska

Is Agnieszka Wierzbowska a top-rated expert for Acute Myeloid Leukemia (AML)?

MediFind is an objective health platform that identifies experts based on real-world data. Agnieszka Wierzbowska is classified as an Distinguished expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Agnieszka Wierzbowska participate in research or clinical trials?

Yes. Agnieszka Wierzbowska has published 84 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Agnieszka Wierzbowska's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Wierzbowska's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile